skip to main content
psychiatry & behavioral healthquestionnaire

PHQ-9 (Patient Health Questionnaire-9)

iatroX editorial team · Updated · Record checked · editorial policy

The PHQ-9 is a 9-item self-report questionnaire that scores each of the DSM criteria for major depressive disorder on a 0–3 severity scale. It is the most widely validated depression screening and severity monitoring tool in primary care worldwide. Total scores range from 0 to 27.

questionnaire

⚠ Any positive response to this item requires immediate clinical assessment for suicidal risk.
evidence

derivation

Developed by Kroenke, Spitzer, and Williams (2001) as part of the Patient Health Questionnaire suite. Derived from the PRIME-MD diagnostic instrument. Validated in 6,000 patients across 8 primary care and 7 obstetrics-gynaecology clinics. Each item maps directly to one of the nine DSM-IV (now DSM-5) diagnostic criteria for major depressive disorder.

validation

Internal consistency: Cronbach's alpha 0.86–0.89. Criterion validity: at a cut-off of ≥10, sensitivity 88% and specificity 88% for major depressive disorder against structured clinical interview. A massive study by Bianchi et al. (2022, n > 58,000) confirmed the PHQ-9 is essentially unidimensional and demonstrates measurement invariance across demographic groups and nationalities. Test-retest reliability is excellent (r = 0.84 between in-person and telephone administration).

guideline endorsements

NICE CG90/CG91 (Depression in Adults): endorses PHQ-9 for severity assessment and treatment monitoring. USPSTF recommends screening for depression in all adults, with the PHQ-9 as a commonly used instrument. Endorsed by the American Psychiatric Association, WHO mhGAP, and the Canadian Network for Mood and Anxiety Treatments (CANMAT).

regional interpretation
UK: NICE recommends PHQ-9 for severity assessment and treatment monitoring in primary care. QOF (Quality and Outcomes Framework) previously incentivised PHQ-9 use in depression management reviews.
US: USPSTF recommends screening for depression in all adults (Grade B recommendation). PHQ-9 is the most commonly used instrument. CMS reimburses for depression screening using PHQ-9.
references
  1. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.PMID: 11556941
  2. Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J Gen Intern Med. 2007;22(11):1596-1602.PMID: 17874169
  3. Bianchi R, Verkuilen J, Schonfeld IS, et al. Is the PHQ-9 fit for purpose as a unidimensional measure of depression? A study involving 58,272 participants from 29 samples. J Affect Disord. 2022;310:207-214.PMID: 35589014
  4. Levis B, Benedetti A, Thombs BD. Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019;365:l1476.PMID: 30967483
  5. NICE Clinical Guideline CG90. Depression in adults: recognition and management. National Institute for Health and Care Excellence; 2009 (updated 2022).link ↗